MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

Search

NeoGenomics Inc

Closed

6.24 -6.73

Overview

Share price change

24h

Current

Min

6.21

Max

6.65

Key metrics

By Trading Economics

Income

-11M

-26M

Sales

-4M

168M

Profit margin

-15.427

Employees

2,200

EBITDA

-10M

-6.3M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+59.97% upside

Dividends

By Dow Jones

Next Earnings

29 Jul 2025

Market Stats

By TradingEconomics

Market Cap

-359M

924M

Previous open

12.97

Previous close

6.24

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

NeoGenomics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

18 Jul 2025, 14:33 UTC

Major Market Movers

MEI Pharma Stock Surges on $100 Million Private Placement, Litecoin Treasury Strategy

17 Jul 2025, 21:14 UTC

Acquisitions, Mergers, Takeovers

Basel Medical Group Puts $1 Billion Bitcoin Purchase on Hold

17 Jul 2025, 18:49 UTC

Acquisitions, Mergers, Takeovers

Bitcoin Standard Treasury to Go Public Via SPAC Deal

14 Jul 2025, 17:06 UTC

Major Market Movers

Crypto Assets Rally Ahead of Possible U.S. Legislation

18 Jul 2025, 14:31 UTC

Market Talk

U.S. Regulation is Driving Crypto Demand -- Market Talk

18 Jul 2025, 14:18 UTC

Major Market Movers

MEI Pharma Stock Surges on $100M Private Placement, Litecoin Treasury Strategy

18 Jul 2025, 07:06 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

18 Jul 2025, 07:06 UTC

Market Talk

Bitcoin Rises on Optimism Over U.S. Regulation -- Market Talk

17 Jul 2025, 21:45 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

17 Jul 2025, 21:45 UTC

Market Talk

Crypto Bills Welcomed by Venture Capital, Trade Group Says -- Market Talk

17 Jul 2025, 20:59 UTC

Acquisitions, Mergers, Takeovers

Basel Medical Group Puts $1B Bitcoin Purchase on Hold

17 Jul 2025, 14:37 UTC

Market Talk

Ethereum Outperforms as Bitcoin Stays Stuck Below $120,000 -- Market Talk

17 Jul 2025, 13:06 UTC

Acquisitions, Mergers, Takeovers

Cantor Equity Partners I, Upon Closing, Combined Company Expected to Trade Under Ticker Symbol BSTR >CEPO

17 Jul 2025, 13:06 UTC

Acquisitions, Mergers, Takeovers

Bitcoin Standard Treasury to Go Public Through Business Combination With Cantor Equity Partners I

17 Jul 2025, 09:19 UTC

Market Talk

Bitcoin Falls, Stays at High Levels Amid Focus on U.S. Legislation -- Market Talk

17 Jul 2025, 09:19 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

16 Jul 2025, 13:41 UTC

Acquisitions, Mergers, Takeovers

This Crypto Stock Is Soaring. Peter Thiel Just Made a Big Bet. -- Barrons.com

16 Jul 2025, 11:16 UTC

Acquisitions, Mergers, Takeovers

This Crypto Stock Soared 30%. Peter Thiel Just Made a Big Bet. -- Barrons.com

16 Jul 2025, 09:05 UTC

Market Talk

Bitcoin Turns Higher Again Ahead of Possible U.S. Legislation -- Market Talk

15 Jul 2025, 15:15 UTC

Market Talk

Sovereign Adoption of Bitcoin is Rising -- Market Talk

15 Jul 2025, 14:40 UTC

Market Talk

Global Equities Roundup: Market Talk

15 Jul 2025, 14:40 UTC

Market Talk

Stablecoins Aren't a Long-Term Store of Value -- Market Talk

15 Jul 2025, 14:05 UTC

Market Talk

Investors More Sensitive to Risk of Crypto Collapse -- Market Talk

15 Jul 2025, 13:20 UTC

Market Talk

Bitcoin's Recent Rally Could Extend Further -- Market Talk

15 Jul 2025, 13:20 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

15 Jul 2025, 12:42 UTC

Market Talk

Global Equities Roundup: Market Talk

15 Jul 2025, 12:42 UTC

Market Talk

Widespread Bitcoin Adoption Is Still Some Way Off -- Market Talk

15 Jul 2025, 08:22 UTC

Market Talk

Bitcoin Hit by Profit-Taking After Surge to Record Highs -- Market Talk

14 Jul 2025, 15:54 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

14 Jul 2025, 15:54 UTC

Market Talk

'Crypto Week' Legislation Would Overhaul U.S. Crypto Policy -- Market Talk

Peer Comparison

Price change

NeoGenomics Inc Forecast

Price Target

By TipRanks

59.97% upside

12 Months Forecast

Average 10.75 USD  59.97%

High 12 USD

Low 8.5 USD

Based on 10 Wall Street analysts offering 12 month price targets forNeoGenomics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

10 ratings

6

Buy

4

Hold

0

Sell

Technical Score

By Trading Central

7.7 / 10.27Support & Resistance

Short Term

Very Strong Bearish Evidence

Intermediate Term

Bearish Evidence

Long Term

Bearish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.